1
|
Pang J, Assaad D, Breen D, et al:
Extramammary Paget disease: review of patients seen in a
non-melanoma skin cancer clinic. Curr Oncol. 17:43–45. 2010.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Martinez JC and Otley CC: The management
of melanoma and nonmelanoma skin cancer: a review for the primary
care physician. Mayo Clin Proc. 76:1253–1265. 2001. View Article : Google Scholar : PubMed/NCBI
|
3
|
Rigel DS: Epidemiology of melanoma. Semin
Cutan Med Surg. 29:204–209. 2010. View Article : Google Scholar
|
4
|
Berwick M: How do solar UV irradiance and
smoking impact the diagnosis of second cancers after diagnosis of
melanoma?: No answer yet. Dermatoendocrinology. 4:18–19. 2012.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Pfeifer GP and Besaratinia A: UV
wavelength-dependent DNA damage and human non-melanoma and melanoma
skin cancer. Photochem Photobiol Sci. 11:90–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Aceituno-Madera P, Buendia-Eisman A, Olmo
FJ, Jimenez-Moleon JJ and Serrano-Ortega S: Melanoma, altitude, and
UV-B radiation. Actas Dermosifiliogr. 102:199–205. 2011.(In
Spanish).
|
7
|
Mathew A, Lindsley TA, Sheridan A, et al:
Degraded mitochondrial DNA is a newly identified subtype of the
damage associated molecular pattern (DAMP) family and possible
trigger of neurodegeneration. J Alzheimers Dis. 30:617–627.
2012.
|
8
|
Baltanas FC, Casafont I, Weruaga E, Alonso
JR, Berciano MT and Lafarga M: Nucleolar disruption and cajal body
disassembly are nuclear hallmarks of DNA damage-induced
neurodegeneration in purkinje cells. Brain Pathol. 21:374–388.
2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Barzilai A: DNA damage, neuronal and glial
cell death and neurodegeneration. Apoptosis. 15:1371–1381. 2010.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Engelmann D and Putzer BM: Translating DNA
damage into cancer cell death-A roadmap for E2F1 apoptotic
signalling and opportunities for new drug combinations to overcome
chemoresistance. Drug Resist Updat. 13:119–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ye Y, Xiao Y, Wang W, et al: Inhibition of
expression of the chromatin remodeling gene, SNF2L, selectively
leads to DNA damage, growth inhibition, and cancer cell death. Mol
Cancer Res. 7:1984–1999. 2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Suganuma M, Kawabe T, Hori H, Funabiki T
and Okamoto T: Sensitization of cancer cells to DNA damage-induced
cell death by specific cell cycle G2 checkpoint abrogation. Cancer
Res. 59:5887–5891. 1999.PubMed/NCBI
|
13
|
Potter AJ and Rabinovitch PS: The cell
cycle phases of DNA damage and repair initiated by topoisomerase
II-targeting chemotherapeutic drugs. Mutat Res. 572:27–44. 2005.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Friedmann B, Caplin M, Hartley JA and
Hochhauser D: Modulation of DNA repair in vitro after treatment
with chemotherapeutic agents by the epidermal growth factor
receptor inhibitor gefitinib (ZD1839). Clin Cancer Res.
10:6476–6486. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kerklaan PR, Bouter S, van Elburg PE and
Mohn GR: Evaluation of the DNA repair host-mediated assay. II
Presence of genotoxic factors in various organs of mice treated
with chemotherapeutic agents. Mutat Res. 164:19–29. 1986.PubMed/NCBI
|
16
|
Norin AJ and Goldschmidt EP: Effect of
mutagens, chemotherapeutic agents and defects in DNA repair genes
on recombination in F′ partial diploid Escherichia coli.
Mutat Res. 59:15–26. 1979.PubMed/NCBI
|
17
|
Hikim AP, Lue YH, Wang C, Reutrakul V,
Sangsuwan R and Swerdloff RS: Posttesticular antifertility action
of triptolide in the male rat: Evidence for severe impairment of
cauda epididymal sperm ultrastructure. J Androl. 21:431–437.
2000.
|
18
|
Zhou GS, Hu Z, Fang HT, et al: Biologic
activity of triptolide in t(8;21) acute myeloid leukemia cells.
Leuk Res. 35:214–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mak DH, Schober WD, Chen W, et al:
Triptolide induces cell death independent of cellular responses to
imatinib in blast crisis chronic myelogenous leukemia cells
including quiescent CD34+ primitive progenitor cells.
Mol Cancer Ther. 8:2509–2516. 2009. View Article : Google Scholar
|
20
|
Shi X, Jin Y, Cheng C, et al: Triptolide
inhibits Bcr-Abl transcription and induces apoptosis in
STI571-resistant chronic myelogenous leukemia cells harboring T315I
mutation. Clin Cancer Res. 15:1686–1697. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Pigneux A, Mahon FX, Uhalde M, et al:
Triptolide cooperates with chemotherapy to induce apoptosis in
acute myeloid leukemia cells. Exp Hematol. 36:1648–1659. 2008.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Yao GH, Luan JF, Ye D, et al: Effects of
triptolide on proliferation and apoptosis of Jurkat cell line in
acute T lymphocytic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
16:506–509. 2008.(In Chinese).
|
23
|
Tong X, Zheng S, Jin J, Zhu L, Lou Y and
Yao H: Triptolide inhibits cyclooxygenase-2 and inducible nitric
oxide synthase expression in human colon cancer and leukemia cells.
Acta Biochim Biophys Sin. 39:89–95. 2007. View Article : Google Scholar : PubMed/NCBI
|
24
|
Lou YJ and Jin J: Triptolide
down-regulates bcr-abl expression and induces apoptosis in chronic
myelogenous leukemia cells. Leuk Lymphoma. 45:373–376. 2004.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Chan EW, Cheng SC, Sin FW and Xie Y:
Triptolide induced cytotoxic effects on human promyelocytic
leukemia, T cell lymphoma and human hepatocellular carcinoma cell
lines. Toxicol Lett. 122:81–87. 2001. View Article : Google Scholar : PubMed/NCBI
|
26
|
Liu J, Shen M, Yue Z, et al: Triptolide
inhibits colon-rectal cancer cells proliferation by induction of G1
phase arrest through upregulation of p21. Phytomedicine.
19:756–762. 2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Liu Y, Song F, Wu WK, et al: Triptolide
inhibits colon cancer cell proliferation and induces cleavage and
translocation of 14-3-3 epsilon. Cell Biochem Funct. 30:271–278.
2012. View
Article : Google Scholar : PubMed/NCBI
|
28
|
Kim MJ, Lee TH, Kim SH, Choi YJ, Heo J and
Kim YH: Triptolide inactivates Akt and induces caspase-dependent
death in cervical cancer cells via the mitochondrial pathway. Int J
Oncol. 37:1177–1185. 2010.PubMed/NCBI
|
29
|
Zhang C, Cui GH, Liu F, Wu QL and Chen Y:
Inhibitory effect of triptolide on lymph node metastasis in
patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis
in vitro. Acta Pharmacol Sin. 27:1438–1446. 2006. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yang S, Chen J, Guo Z, et al: Triptolide
inhibits the growth and metastasis of solid tumors. Mol Cancer
Ther. 2:65–72. 2003.PubMed/NCBI
|
31
|
Hsiao YP, Yu CS, Yu CC, et al: Triggering
apoptotic death of human malignant melanoma a375. S2 cells by
bufalin: involvement of caspase cascade-dependent and independent
mitochondrial signaling pathways. Evid Based Complement Alternat
Med. 2012:5912412012. View Article : Google Scholar
|
32
|
Lo C, Lai TY, Yang JS, et al: Gallic acid
inhibits the migration and invasion of A375. S2 human melanoma
cells through the inhibition of matrix metalloproteinase-2 and Ras.
Melanoma Res. 21:267–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
33
|
Yu CS, Huang AC, Yang JS, et al: Safrole
induces G0/G1 phase arrest via inhibition of cyclin E and provokes
apoptosis through endoplasmic reticulum stress and
mitochondrion-dependent pathways in human leukemia HL-60 cells.
Anticancer Res. 32:1671–1679. 2012.
|
34
|
Liu KC, Ho HC, Huang AC, et al: Gallic
acid provokes DNA damage and suppresses DNA repair gene expression
in human prostate cancer PC-3 cells. Environ Toxicol. Sept
2–2011.(Epub ahead of print).
|
35
|
Ni CH, Yu CS, Lu HF, et al:
Chrysophanol-induced cell death (necrosis) in human lung cancer
A549 cells is mediated through increasing reactive oxygen species
and decreasing the level of mitochondrial membrane potential.
Environ Toxicol. Jul 30–2012.(Epub ahead of print).
|
36
|
Yu CC, Ko FY, Yu CS, et al: Norcantharidin
triggers cell death and DNA damage through S-phase arrest and
ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder
carcinoma cells. Int J Oncol. 41:1050–1060. 2012.
|
37
|
Ni CH, Chen PY, Lu HF, et al:
Chrysophanol-induced necrotic-like cell death through an impaired
mitochondrial ATP synthesis in Hep3B human liver cancer cells. Arch
Pharm Res. 35:887–895. 2012. View Article : Google Scholar : PubMed/NCBI
|
38
|
Tsai SC, Yang JS, Peng SF, et al: Bufalin
increases sensitivity to AKT/mTOR-induced autophagic cell death in
SK-HEP-1 human hepatocellular carcinoma cells. Int J Oncol.
41:1431–1442. 2012.PubMed/NCBI
|
39
|
Chen HY, Lu HF, Yang JS, et al: The novel
quinolone CHM-1 induces DNA damage and inhibits DNA repair gene
expressions in a human osterogenic sarcoma cell line. Anticancer
Res. 30:4187–4192. 2010.PubMed/NCBI
|
40
|
Lin YT, Yang JS, Lin SY, et al: Diallyl
disulfide (DADS) induces apoptosis in human cervical cancer Ca Ski
cells via reactive oxygen species and Ca2+-dependent
mitochondria-dependent pathway. Anticancer Res. 28:2791–2799.
2008.PubMed/NCBI
|
41
|
Chen YY, Chiang SY, Lin JG, et al: Emodin,
aloe-emodin and rhein induced DNA damage and inhibited DNA repair
gene expression in SCC-4 human tongue cancer cells. Anticancer Res.
30:945–951. 2010.PubMed/NCBI
|
42
|
Ho YT, Lu CC, Yang JS, et al: Berberine
induced apoptosis via promoting the expression of caspase-8, -9 and
-3, apoptosis-inducing factor and endonuclease G in SCC-4 human
tongue squamous carcinoma cancer cells. Anticancer Res.
29:4063–4070. 2009.
|
43
|
Lu HF, Yang JS, Lai KC, et al:
Curcumin-induced DNA damage and inhibited DNA repair genes
expressions in mouse-rat hybrid retina ganglion cells (N18).
Neurochem Res. 34:1491–1497. 2009. View Article : Google Scholar : PubMed/NCBI
|
44
|
Ji BC, Yu CC, Yang ST, et al: Induction of
DNA damage by deguelin is mediated through reducing DNA repair
genes in human non-small cell lung cancer NCI-H460 cells. Oncol
Rep. 27:959–964. 2012.PubMed/NCBI
|
45
|
Wu PP, Liu KC, Huang WW, et al: Triptolide
induces apoptosis in human adrenal cancer NCI-H295 cells through a
mitochondrial-dependent pathway. Oncol Rep. 25:551–557.
2011.PubMed/NCBI
|
46
|
Huang W, He T, Chai C, et al: Triptolide
inhibits the proliferation of prostate cancer cells and
down-regulates SUMO-specific protease 1 expression. PLoS One.
7:e376932012. View Article : Google Scholar : PubMed/NCBI
|
47
|
Petriccione M and Ciniglia C: Comet assay
to assess the genotoxicity of Persian walnut (Juglans regia
L.) husks with statistical evaluation. Bull Environ Contam Toxicol.
89:166–171. 2012. View Article : Google Scholar : PubMed/NCBI
|
48
|
Kwasniewska J, Grabowska M, Kwasniewski M
and Kolano B: Comet-FISH with rDNA probes for the analysis of
mutagen-induced DNA damage in plant cells. Environ Mol Mutagen.
53:369–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
49
|
Goutham HV, Mumbrekar KD, Vadhiraja BM, et
al: DNA double-strand break analysis by γ-H2AX foci: A useful
method for determining the overreactors to radiation-induced acute
reactions among head-and-neck cancer patients. Int J Radiat Oncol
Biol Phys. Jul 24–2012.(Epub ahead of print).
|
50
|
Savina NV, Smal MP, Kuzhir TD,
Ershova-Pavlova AA and Goncharova RI: DNA-damage response
associated with occupational exposure, age and chronic inflammation
in workers in the automotive industry. Mutat Res. 748:21–28. 2012.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Pennington KP, Walsh T, Lee M, et al:
BRCA1, TP53, and CHEK2 germline mutations in uterine serous
carcinoma. Cancer. Jul 18–2012.(Epub ahead of print).
|
52
|
Serrano MA, Li Z, Dangeti M, et al:
DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to
facilitate homologous recombination DNA repair. Oncogene. Jul
16–2012.(Epub ahead of print).
|
53
|
Fortini P, Ferretti C, Pascucci B, et al:
DNA damage response by single-strand breaks in terminally
differentiated muscle cells and the control of muscle integrity.
Cell Death Differ. Jun 15–2012.(Epub ahead of print).
|
54
|
Jia YG, Yang YM, Zuo B, Guo LD and Lou JY:
DNA damage response in ovarian clear cell adenocarcinoma. Sichuan
Da Xue Xue Bao Yi Xue Ban. 43:331–334. 2012.(In Chinese).
|
55
|
Wong VC, Cash HL, Morse JL, Lu S and
Zhitkovich A: S-phase sensing of DNA-protein crosslinks triggers
TopBP1-independent ATR activation and p53-mediated cell death by
formaldehyde. Cell Cycle. 11:2526–2537. 2012. View Article : Google Scholar : PubMed/NCBI
|
56
|
Boltz KA, Leehy K, Song X, Nelson AD and
Shippen DE: ATR cooperates with CTC1 and STN1 to maintain telomeres
and genome integrity in Arabidopsis. Mol Biol Cell. 23:1558–1568.
2012. View Article : Google Scholar : PubMed/NCBI
|
57
|
Tammaro C, Raponi M, Wilson DI and Baralle
D: BRCA1 exon 11 alternative splicing, multiple functions and the
association with cancer. Biochem Soc Trans. 40:768–772. 2012.
View Article : Google Scholar : PubMed/NCBI
|
58
|
Pessetto ZY, Yan Y, Bessho T and Natarajan
A: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances
the cytotoxic effect of olaparib in breast cancer cells: a proof of
concept study for synthetic lethal therapeutic option. Breast
Cancer Res Treat. 134:511–517. 2012. View Article : Google Scholar
|
59
|
Yarden RI, Metsuyanim S, Pickholtz I,
Shabbeer S, Tellio H and Papa MZ: BRCA1-dependent Chk1
phosphorylation triggers partial chromatin disassociation of
phosphorylated Chk1 and facilitates S-phase cell cycle arrest. Int
J Biochem Cell Biol. 44:1761–1769. 2012. View Article : Google Scholar : PubMed/NCBI
|
60
|
Silber JR, Bobola MS, Blank A and
Chamberlain MC: O(6)-Methylguanine-DNA methyltransferase in glioma
therapy: Promise and problems. Biochim Biophys Acta. 1826:71–82.
2012.PubMed/NCBI
|
61
|
Fumagalli C, Pruneri G, Possanzini P, et
al: Methylation of O6-methylguanine-DNA methyltransferase (MGMT)
promoter gene in triple-negative breast cancer patients. Breast
Cancer Res Treat. 134:131–137. 2012. View Article : Google Scholar : PubMed/NCBI
|